[1] Mongroo PS, Rustgi AK. The role of the mir-200 family in epithelial-mesenchymal transition[J]. Cancer Biol Ther, 2010, 10(3): 219-222.
[2] Sun Y, Shen S, Liu X, et al. miR-429 inhibits cells growth and invasion and regulates emt-related marker genes by targeting onecut2 in colorectal carcinoma[J]. Mol Cell Biol, 2014, 390(1-2): 19-30.
[3] Ye ZB, Ma G, Zhao YH, et al. miR-429 inhibits migration and invasion of breast cancer cells in vitro[J]. Int J Oncol, 2015, 46(2): 531-538.
[4] Gao H, Liu C. miR-429 represses cell proliferation and induces apoptosis in hbv-related hcc[J]. Biome Pharmacother, 2014, 68(8): 943-949.
[5] Wu N, Zhang C, Bai C, et al. Mir-4782-3p inhibited non-small cell lung cancer growth via usp14[J]. Cell Physiol Biochem, 2014, 33(2): 457-467.
[6] van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the mtt assay[J]. Methods Mol Biol, 2011, 731: 237-245.
[7] Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets[J]. Cell, 2005, 120(1): 15-20.
[8] Friedman RC, Farh KK, Burge CB,et al. Most mammalian mrnas are conserved targets of micrornas[J]. Genome Res, 2009, 19(1): 92-105.
[9] Grimson A, Farh KK, Johnston WK, et al. Microrna targeting specificity in mammals: determinants beyond seed pairing[J]. Mol Cell, 2007, 27(1): 91-105.
[10] Garcia DM, Baek D, Shin C, et al. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other micrornas[J]. Nat Struct Mol Biol, 2011, 18(10): 1139-1146.
[11] Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer[J]. Nat Rev Cancer, 2011, 11(1): 9-22.
[12] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[13] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2011, 61(1): 10-29.
[14] Haddad RI, Shin DM. Recent advances in head and neck cancer[J]. N Engl J Med, 2008, 359(11): 1143-1154.
[15] Sun T, Wang C, Xing J, et al. miR-429 modulates the expression of c-myc in human gastric carcinoma cells[J]. Eur J Cancer, 2011, 47(17): 2552-2559.
[16] Uhlmann S, Zhang JD, Schwager A, et al. Mir-200bc/429 cluster targets plcgamma1 and differentially regulates proliferation and egf-driven invasion than mir-200a/141 in breast cancer[J]. Oncogene, 2010, 29(30): 4297-4306.
[17] Liu X, Liu Y, Wu S, et al. Tumor-suppressing effects of miR-429 on human osteosarcoma[J]. Cell Biochem Biophys, 2014, 70(1): 215-224.
[18] Snowdon J, Zhang X, Childs T, et al. The microrna-200 family is upregulated in endometrial carcinoma[J]. PLoS One, 2011, 6(8): e22828.
[19] Han Y, Chen J, Zhao X, et al. Microrna expression signatures of bladder cancer revealed by deep sequencing[J]. PLoS One, 2011, 6(3): e18286.
[20] Nam EJ, Yoon H, Kim SW, et al. Microrna expression profiles in serous ovarian carcinoma[J]. Clin Cancer Res, 2008, 14(9): 2690-2695.
[21] Wellner U, Schubert J, Burk UC, et al. The emt-activator zeb1 promotes tumorigenicity by repressing stemness-inhibiting micrornas[J]. Nature Cell Biol, 2009, 11(12): 1487-1495. |